Refresh

SOL Pharmaceuticals Ltd. - Research Center

500393 SOLPHR--Z Group (N.A.) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 00
Income

Operating income

28.27
Expenses

Material consumed

18.00

Manufacturing expenses

7.39

Personnel expenses

5.13

Selling expenses

0.06

Adminstrative expenses

1.90

Expenses capitalised

-

Cost of sales

32.48

Operating profit

-4.20

Other recurring income

1.40

Adjusted PBDIT

-2.80

Financial expenses

51.14

Depreciation

2.90

Other write offs

6.14

Adjusted PBT

-62.98

Tax charges

-

Adjusted PAT

-

Non recurring items

-0.02

Other non cash adjustments

-0.06

Reported net profit

-63.06

Earnigs before appropriation

-363.16

Equity dividend

-

Preference dividend

-

Dividend tax

-

Retained earnings

-363.16
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com